For US residents only.

Live in the Moment

When you're living with the severe diarrhea and flushing associated with carcinoid syndrome

Important Safety Information

Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, sugar metabolism, thyroid and heart function, and nutritional absorption, which may require monitorin...

See More
Approved Use:

Sandostatin® LAR Depot (octreotide acetate for injectable suspension) is indicated for patients in whom initial treatment with immediate release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated for:

  • Long-term treatment of the severe diarrhea ...
See More

*Includes Sandostatin® (octreotide acetate) Immediate-release Injection and Sandostatin® LAR Depot (octreotide acetate for injectable suspension) for all approved indications.

learn more about

Sandostatin LAR Depot

Sandostatin LAR Depot works by blocking the production of a number of hormones that can lead to severe diarrhea and flushing associated with carcinoid syndrome. Your doctor will identify if Sandostatin LAR Depot is right for you based on your response to, and how well you tolerate, 2 weeks of treatment with Sandostatin® (octreotide acetate) Immediate-release Injection.

Learn More
learn more about

Support Services

Find information and support specifically designed to help patients diagnosed with severe diarrhea and flushing associated with carcinoid syndrome, to access the materials and tools they need to help understand their disease, including nutritional info, recipes, patient stories, and more.